Weili Medical (603309.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 148 million yuan, a year-on-year decrease of 22.61%.

Zhitong Finance APP News, Well Lead Medical (603309.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.218 billion yuan, a year-on-year increase of 2.22%; net profit attributable to shareholders of the listed company was 148 million yuan, a year-on-year decrease of 22.61%; net profit after deducting non-recurring gains and losses was 143 million yuan, a year-on-year decrease of 22.60%; basic earnings per share were 0.51 yuan. The company plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders.